Philip L Johnson is EVP & Chief Financial Officer of Jazz Pharmaceuticals plc. Currently has a direct ownership of 50,060 shares of JAZZ, which is worth approximately $5.15 Million. The most recent transaction as insider was on Mar 05, 2025, when has been sold 1,149 shares (Ordinary Shares) at a price of $138.95 per share, resulting in proceeds of $159,653. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.1K
79.22% 3M change
79.22% 12M change
Total Value Held $5.15 Million

Philip L Johnson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 05 2025
SELL
Sale (or disposition) back to the issuer
$159,653 $138.95 p/Share
1,149 Reduced 2.24%
50,060 Ordinary Shares
Feb 27 2025
BUY
Grant, award, or other acquisition
-
23,111 Added 31.1%
51,209 Ordinary Shares
Mar 01 2024
BUY
Open market or private purchase
$1,435,800 $119.65 p/Share
12,000 Added 30.05%
27,932 Ordinary Shares
Mar 01 2024
BUY
Grant, award, or other acquisition
-
15,932 Added 50.0%
15,932 Ordinary Shares
PLJ

Philip L Johnson

EVP & Chief Financial Officer
Dublin 4, L2

Track Institutional and Insider Activities on JAZZ

Follow Jazz Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

News

Receive news related to Jazz Pharmaceuticals plc

Track Activities on JAZZ